時間 | 主題 | 講者 | 座長 |
---|---|---|---|
10:30 ~ 10:37 |
Magnetic hyperthermia using a novel iron oxide nanoparticle with carbon nanohorn suppressed tumor growth in castration-resistant prostate cancer |
Takashi Nagai |
吳俊德, 黃國皓 |
10:37 ~ 10:44 |
Tumor involving below upper ureter is a significant prognostic factor for upper tract urothelial carcinoma: A large retrospective cohort study |
黃英哲 |
吳俊德, 黃國皓 |
10:44 ~ 10:51 |
Clinical characteristics and outcomes of young patients with upper urinary tract urothelial carcinoma |
陳至亨 |
吳俊德, 黃國皓 |
10:51 ~ 10:58 |
The outcome of neoadjuvant immunotherapy for muscle-invasive urinary bladder urothelial carcinoma: single-center experience |
邱亮維 |
吳俊德, 黃國皓 |
10:58 ~ 11:05 |
The timing and prevention of skeletal-related events in metastatic prostate cancer patients |
李采霓 |
吳俊德, 黃國皓 |
11:05 ~ 11:12 |
Concomitant carcinoma in situ is an independent prognostic predictor for patients with localized lymph node negative upper-tract urothelial carcinoma undergoing nephroureterectomy |
謝尚儒 |
吳俊德, 黃國皓 |
11:12 ~ 11:19 |
Oncological and renal function outcomes of segmental ureterectomy versus radical nephroureterectomy for urothelial carcinoma of the ureter |
陳思翰 |
吳俊德, 黃國皓 |
11:19 ~ 11:26 |
Long-term outcomes of and nomograms for high-risk prostate cancer patients treated with primary total prostate cryoablation |
謝宗頤 |
吳俊德, 黃國皓 |
11:26 ~ 11:33 |
Is extraperitoneal robotic-assisted radical prostatectomy feasible for patients with prior lower abdominal surgery- a single surgeon series |
黃文齊 |
吳俊德, 黃國皓 |
11:33 ~ 11:40 |
Hydronephrosis has protective role against renal function decline after nephroureterectomy in patients with upper tract urothelial carcinoma |
徐任廷 |
吳俊德, 黃國皓 |
11:40 ~ 11:47 |
Prostate biopsy strategy integrating prostate health index and multiparametric magnetic resonance imaging optimizes the predictive value of clinically significant prostate cancer in prostate imaging reporting and data system gray-zone imaging |
邱士庭 |
吳俊德, 黃國皓 |